Bentham Science Logo

Track Your Manuscript:


Current Cancer Drug Targets

Volume 20, 11 Issues, 2020
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Current Cancer Drug Targets, Volume 12 - Number 7



Molecular Targets for the Treatment of Multiple Myeloma

, 12(7): 757 - 767

Marco Rossi, Maria Teresa Di Martino, Eugenio Morelli, Marzia Leotta, Antonietta Rizzo, Anna Grimaldi, Gabriella Misso, Pierfrancesco Tassone and Michele Caraglia


DOI: 10.2174/156800912802429300






MicroRNAs in the Pathobiology of Multiple Myeloma

, 12(7): 823 - 837

Marta Lionetti, Luca Agnelli, Luigia Lombardi, Pierfrancesco Tassone and Antonino Neri


DOI: 10.2174/156800912802429274


Promises and Challenges of MicroRNA-based Treatment of Multiple Myeloma

, 12(7): 838 - 846

P. Tagliaferri, M. Rossi, M. T. Di Martino, N. Amodio, E. Leone, A. Gulla, A. Neri and P. Tassone


DOI: 10.2174/156800912802429355


Anti-Tumor Effect of AlkB Homolog 3 Knockdown in Hormone- Independent Prostate Cancer Cells

, 12(7): 847 - 856

K. Koike, Y. Ueda, H. Hase, K. Kitae, Y. Fusamae, S. Masai, T. Inagaki, Y. Saigo, S. Hirasawa, K. Nakajima, I. Ohshio, Y. Makino, N. Konishi, H. Yamamoto and K. Tsujikawa


DOI: 10.2174/156800912802429283





Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
View Full Editorial Board

COPE Compliant

Journal History

Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.75

Advertisement

New Year Offer 2021Covid Resource Center

Related Journals

Related eBooks

eBooks Catalog